Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Pharma - API & CRAMS
  4. /Blue Jet Healthcare Ltd
MomentumDeep Value

Blue Jet Healthcare Ltd: Stock Analysis & Fundamentals

Updated this week

Blue Jet Healthcare Ltd (Pharma - API & CRAMS) — fundamental analysis, earnings data, and key metrics. PE: 20.3. ROE: 30.2%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

👔Promoter stake down 6.2% this quarter
🏛️DII accumulation — stake up 1.9%

Key Numbers

Current Price
₹344
Dividend Yield
0.35%
Market Cap
6.0K Cr
Valuation
N/A

Other Top Pharma - API & CRAMS Stocks Beating Nifty 500

Gland Pharma Ltd
Average
+15.9%
Acutaas Chemicals Ltd
Average • 9w streak
+65.6%
Granules India Ltd
Average • 6w streak
+12.7%
SMS Pharmaceuticals Ltd
Average • 12w streak
+37.7%
← Back to Pharma - API & CRAMSDashboard

Frequently Asked Questions: Blue Jet Healthcare Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Blue Jet Healthcare Ltd's latest quarterly results?

Blue Jet Healthcare Ltd's latest quarterly results (Dec 2025) show

  • PAT Growth YoY: -59.6%
  • Revenue Growth YoY: -39.6%
  • Operating Margin: 24.0%

What is Blue Jet Healthcare Ltd's current PE ratio?

Blue Jet Healthcare Ltd's current PE ratio is 20.3x.

  • Current PE: 20.3x
  • Market Cap: 6.0K Cr
  • Dividend Yield: 0.35%

What is Blue Jet Healthcare Ltd's price-to-book ratio?

Blue Jet Healthcare Ltd's price-to-book ratio is 4.8x.

  • Price-to-Book (P/B): 4.8x
  • Book Value per Share: ₹72
  • Current Price: ₹344

Is Blue Jet Healthcare Ltd a fundamentally strong company?

Blue Jet Healthcare Ltd's fundamental strength based on key financial ratios

  • Return on Capital (ROCE): 40.0%

Is Blue Jet Healthcare Ltd debt free?

Blue Jet Healthcare Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹21 Cr

What is Blue Jet Healthcare Ltd's return on equity (ROE) and ROCE?

Blue Jet Healthcare Ltd's return ratios over recent years

  • FY2023: ROCE 35.0%
  • FY2024: ROCE 30.0%
  • FY2025: ROCE 40.0%

Is Blue Jet Healthcare Ltd's cash flow positive?

Blue Jet Healthcare Ltd's operating cash flow is positive (FY2025).

  • Cash from Operations (CFO): ₹46 Cr
  • Free Cash Flow (FCF): ₹11 Cr
  • CFO/PAT Ratio: 15% (weak cash conversion)

What is Blue Jet Healthcare Ltd's dividend yield?

Blue Jet Healthcare Ltd's current dividend yield is 0.35%.

  • Dividend Yield: 0.35%
  • Current Price: ₹344

Who holds Blue Jet Healthcare Ltd shares — promoters, FII, DII?

Blue Jet Healthcare Ltd's shareholding pattern (Dec 2025)

  • Promoters: 79.8%
  • FII (Foreign): 1.1%
  • DII (Domestic): 4.7%
  • Public: 14.4%

Is promoter holding increasing or decreasing in Blue Jet Healthcare Ltd?

Blue Jet Healthcare Ltd's promoter holding has remained stable recently.

  • Current Promoter Holding: 79.8% (Dec 2025)
  • Previous Quarter: 79.8% (Sep 2025)
  • Change: 0.00% (stable)

Is Blue Jet Healthcare Ltd a new momentum entry or an established outperformer?

Blue Jet Healthcare Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Blue Jet Healthcare Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Blue Jet Healthcare Ltd may be worth studying

  • Cash flow is positive — CFO ₹46 Cr

What is the investment thesis for Blue Jet Healthcare Ltd?

Blue Jet Healthcare Ltd investment thesis summary:

What is the future outlook for Blue Jet Healthcare Ltd?

Blue Jet Healthcare Ltd's forward outlook based on current data signals

  • Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.